To compare the clinical effectiveness of total (TS) or partial (PS) splenectomy in pediatric hereditary spherocytosis, a systematic review and meta-analysis was performed (PROSPERO registration CRD42015030056). There were 14 observational studies comparing pre-and postoperative hematologic parameters. Secondary outcomes include in-hospital infections, surgical complications, symptomatic recurrence and biliary disease. TS is more effective than PS to increase hemoglobin (3.6 g/dL vs 2.2 g/dL) and reduce reticulocytes (12.5% vs 6.5%) after one year; outcomes following PS are stable for at least 6 years. There were no cases of overwhelming post-splenectomy sepsis. A population-based patient registry is needed for long-term follow-up.
Introduction
Hereditary spherocytosis (HS) is a rare genetic disease affecting the erythrocyte cell membrane, producing characteristically spherical erythrocytes (spherocytes). The worldwide prevalence of HS is approximately 1 in 2,000 people [1] [2] [3] . The main molecular defects in HS arise from a heterogeneous set of mutations to cytoskeletal proteins facilitating linkage to the lipid bilayer [4] , Weakening the mechanical integrity of the cell membrane. Signs and symptoms of HS may include splenomegaly, severe anemia, jaundice, reticulocytosis, fatigue, abdominal discomfort [5] . These symptoms are widely recognized to be caused by hemolysis of immature reticulocytes undergoing conditioning in the spleen.
The degree of splenomegaly is a generally reliable indicator of the severity of hemolysis, anemia and risk of developing gall stones. An enlarged spleen is also vulnerable to traumatic rupture. If the degree of anemia is too great, surgical management of HS by splenectomy remains the only intervention. Management of HS by splenectomy has historically been focused on total splenectomy (TS) which was performed through a laparotomy incision. In the early 1990s, the laparoscopic approach was successfully adopted for splenectomy in HS patients [6] , and became a more popular choice of technique. The spleen is a major lymphoid organ in the body and the risk of infection caused by staphylococci and Gram-negative enteric organisms is high in the early post-operative period. Following TS, there is increased susceptibility for many years to potentially fatal overwhelming post-splenectomy sepsis (OPSS; otherwise called overwhelming postsplenectomy infection) from these encapsulated bacteria such as pneumococci, Neisseria meningitides, Haemophilus influenzae and staphylococci [7] . The risk of OPSS from these organisms has been reduced as most centres across North America and Europe use prophylactic 3 vaccinations and prophylactic antibiotics prior to elective splenectomy, and if possible, delay the surgery until the patient over five years old [4] . It is suggested that PS confers some residual immune competence against encapsulated organisms. The level of circulating IgM memory B cells after splenectomy and the percentage of pitted erythrocytes have been used as surrogate markers for immune competence against encapsulated organisms or residual splenic function [8, 9] .
However, these observations need further validation through prospective, controlled studies. This review aims to determine how PS and TS compare when performed for pediatric HS.
Methods

Systematic Review Protocol
Methods of the present systematic review and meta-analysis were pre-specified and documented in a protocol (PROSPERO registration CRD42015030056). The study question was translated into a PICO-formatted grid and was developed to guide the selection of appropriate search terms (Table I) , in accordance with the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines [10] (Supplemental Table SI ).
The population of interest (P) were children, 18 years of age or younger, diagnosed with HS. The intervention (I) was a PS as compared (C) to TS, performed to correct anemia, the primary indicator of HS severity. While PS can be performed as one of two surgical procedures, a less aggressive PS and a more aggressive near-total splenectomy, both are treated as PS for this review.
The former leaves between a splenic remnant of about 15-30% in size; the latter leaves a splenic remnant supplied by a single pedicle, of about 10-15% [11] . This choice is left to the experience of surgeon. The specific surgical technique was not considered here. Primary outcomes (O), chosen based on a pilot search, were pre-and post-operative hemoglobin concentration (g/dL) and 4 percent reticulocytes because these are the most commonly reported outcomes, and often only with one year of follow-up; these were of primary interest because they are a marker of anemia and erythropoiesis, respectively. Secondary outcomes included in-hospital infections, surgical complications, biliary disease, OPSS, recurrence of symptoms and splenosis. All study designs (S) were included for initial screening except case-series with less than five cases.
Search Strategy
A systematic literature search protocol was conducted with the help of a research librarian using the PubMed, EMBASE, Web of Science and CINAHL databases up to Oct. 1, 2015 for studies published with English full-text. Search terms regarding the population of interest, intervention and indication, and comparator and outcome were used to identify eligible studies ( Table I) . The reference lists of relevant articles were then manually searched for additional studies.
Grey literature are publications produced by individuals or organizations, considered to be outside of the traditional commercial or academic publishing and distribution channels; sources searched using "spherocytosis" or "splenectomy" include: clinical trial databases (UK Clinical Trials Gateway; ClinicalTrials.gov), systematic review registries (Cochrane Library; PROSPERO), thesis depositories (Library and Archives Canada; NTLTD, EThOS), health service agencies (WHO; US CDC, Health Canada; CADTH) and grey literature-specific databases (OpenGrey; Grey Literature Report). One clinical trial was identified (NCT01276561) but excluded for lack of relevance and have not yet published any results. Some authors were contacted by e-mail to provide further details, yet was supplied in only one case [12] .
Study screening
All retrieved studies from database searches were included in the screening process to create a systematic, precise, and validated search strategy. Records were imported into EPPIReviewer (version 4.5), duplicates removed, and remaining entries were screened on title and abstract for relevance, and full-text for full consideration. Additionally, eligible studies were included after reading relevant review articles and their reference lists. A complete list of inclusion and exclusion criteria is presented in Table II . Studies were not included if they failed to report on a relevant outcome.
Articles were screened by two independent reviewers in three levels (title, abstract and fulltext) and differences were resolved by consensus. Level 1 (title) screening was based on relevance, level 2 (abstract) screening ruled in studies based on patient population and outcomes, and level 3 (full-text) screening was carried out on studies that might satisfy all criteria of the PICOS. Level 3 screening inter-rater agreement was 83% (kappa=0.64). Then each article was critically appraised and a risk of bias assessment was made using Downs and Black checklist [13] , which was originally validated for appraising surgical interventions. Downs and Black score ranges were given corresponding quality levels as previously outlined: excellent (26) (27) (28) ; good (20) (21) (22) (23) (24) (25) ; fair (15) (16) (17) (18) (19) ; and poor (≤14) [14] . Articles rated as poor were excluded for severe risk of bias. In total, 14 studies met the sufficient quality criteria and were included in this meta-analysis (Table III ) [12, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] .
Meta-analysis and publication bias
Data were extracted into a spreadsheet for analysis. Hemoglobin and percent reticulocytes were compared using the pre-to post-op difference. When the standard deviation of an estimate was not reported, it was calculated where possible or estimated from individual patient data. A 6 fixed-effects model was used to explore the overall effect of surgery, where each study was weighted by the inverse variance method (Figure 1 ). To assess heterogeneity between studies, the chi-square test and I 2 statistic were calculated; an I 2 value greater than 75% suggested high heterogeneity among studies. Publication bias was assessed by inspecting the funnel plot and
Egger's method.
Results
Study Characteristics
From the initial search there were 23 studies included after full-text screening for quality review ( Figure 1 ). In total, 14 observational studies were included after risk of bias assessment with a total of 2,224 patients, including one cross-sectional study (Table III) to -12.2%) after three to four years ( Figure 4B ), and 7.8% (95% CI: -10.7% to -4.9%) after five to six years ( Figure 4C ). Percent reticulocytes remain persistently decreased from baseline by about half to a final value around 4-6%. The profile for TS is more limited but also greater in magnitude after one year, decreasing by an average of 12.5% (95% CI: -12.7% to -12.2%) to about 2-3% after one year ( Figure 4A ). This magnitude of effect of TS is heterogeneous, and could be a result of selection bias if those children undergoing TS had larger spleens or more severe hemolysis. It is expected that erythropoiesis correlates with the degree of hemolysis and therefore TS should have a greater effect than PS. The largest study of TS in this review does not include lab or clinical values [27] .
Infections and Mortality
Fatal events were extremely rare across all reported studies. One 4-year old female died due to unrelated splenic necrosis 8 weeks following PS [11, 24] , in a total of 2,119 reported patients across 13 studies, and no reported cases of OPSS. The study of 1,657 TS patients [27] used the Agency for Healthcare Research and Quality's Pediatric Quality Indicators to profile the safety of the procedure. The found in-hospital pneumonia was extremely rare (<0.6%). A study of similar magnitude for PS has yet to be conducted.
Presence of Accessory Spleens
Four studies reported that 4.5% of HS patients have accessory spleen(s) (80/1,770) but the best estimate in this review is about 3.6% (59/1,657) [27] . This is likely to be underestimated due to a lack of reporting, but is on the low end of the estimated 4-27% reported for other conditions ( [28, 29] and references within). When present, surgeon preferences affect the decision to remove accessory spleens, where some choose to remove them routinely [26] , whereas others do not [18] , with no completion splenectomy after two years in these patients.
Splenic remnant regrowth
The volume of regrowth is highly heterogeneous, ranging from 0-170% of its initial size [20, 24] , consistent with others [30] . Remnant regrowth is does not appear to be associated with recurring anemia [24, 30] , however, regrowth is lowest at younger age and severe disease [24] .
Splenomegaly, recurrence of symptoms and secondary splenectomy
Splenomegaly was reported in 241 of 1,716 individuals (14.0%). Only with excessively large spleens (greater than 1,500 g), do laparoscopic techniques become cumbersome. Recurrence of symptoms (anemia, jaundice, fatigue or abdominal pain) was not common (5-10%), and in some, secondary splenectomy was indicated (5%) [15, 16, 20, 23, 24] .
In-hospital complications and adverse surgical events
Paralytic ileus was the most common in-hospital complication (1.5%), followed by urinary and respiratory complications (1% each), acute pancreatitis and accidental puncture or laceration during surgery (<1% each) [27] . One HS patient had a sequestration crisis following splenectomy [21] .
Cholelithiasis and cholecystitis
Biliary disease is among the most common associated problem with long-standing hemolysis. Among TS patients, cholecystectomy was the most common concurrent procedure (26.7%), of which, 40% suffered from cholelithiasis [27] . The role of prophylactic cholecystectomy performed during splenectomy in children suffering from HS was questioned in the late 1990s [31] , who found that this was indicated when symptomatic gall stones were present.
The degree of splenectomy does not seem to be associated with cholecystectomy and cholelithiasis.
Patient health measures and quality of life
Following splenectomy, abdominal pain was improved [19, 20] , sleep quality improved [32] and two studies noted growth spurts in children [15, 32] . Lastly, three studies reported that quality of life improved using a composite score of some or all of pain, chronic fatigue, or return to physical exercise [15, 16, 32] . These quality of life metrics were not described using standard assessment tools and are open to interpretation. Clinical experience would suggest splenectomy is favourably improves pain and quality of life, despite the residual risk of PS for recurrent anemia.
Length of hospital stay and duration of surgery
While duration of hospital stay and duration of surgery have been reported to be different between TS and PS, these data suggests that they are comparable. The length of stay for TS is between 2-4 days [27] . However, more recent studies on TS find shorter stays of 1-4 days.
Likewise, length of stay for PS was 2-4 days. Surgeries that are uncomplicated and performed without additional procedures are typically 50-75 minutes. Both length of stay and duration of surgery will be influenced by the surgeon's technical proficiency and experience.
Discussion
This meta-analysis finds that both total and PS adequately resolve short-term anemia in pediatric HS patients. There is a general theme that there is longer follow-up data available for PS patients, and the extent of detailed reporting varies. In the short-term post-operative period, splenectomy is generally safe and well tolerated, with extremely low risk of death and no reported cases of OPSS. This agrees with a meta-analysis which included adult hemolytic anemia patients [33] .
Consensus guidelines for which data should be collected during routine monitoring of the HS patient are needed. For instance, hemoglobin concentration and reticulocytes are inexpensive and worthwhile to collect. For this reason and based on a pilot search of the literature, they were used in this review because of their relation to anemia and splenic function, and also that anemia is an independent risk factor of future cardiovascular disease [34] . abdominal pain and return to physical activity were infrequently described, but can be quickly and easily determined using a standardized questionnaire. The goal of a related, on-going clinical trial is to examine the patients' perception of scar formation, suggesting that cosmesis is an important factor to some patients and their families.
Measures of splenic function need also to be collected and validated prospectively. Pitted erythrocytes, measured by phase microscopy, are the gold standard of phagocytic function and is widely available. The normal clinical range is 0-4%, but may increase to 70% in clinically relevant splenomegaly. Data from sickle cell patients suggest a value of 15% or less is associated with immune competence and fewer instances of sepsis [35] [36] [37] . In contrast, Howell-Jolly bodies poorly correlate with other measurements [8] . Imaging modalities may be used for functional assessment. MRI can measure splenic volume in HS [23] and splenosis [29] . Scintigraphic scans using 99m-technetium labelled heat-damaged, autologous erythrocytes measure splenic function due to (mostly) splenic sequestration of the cell membranes, and splenic volume. However, scintigraphy is unlikely to be a cost-effect or common option in the pediatric population, and is only available in specialized centres. There is the possibility that sequestration-based measures in HS patients are at risk of increased false positives and could diminish its diagnostic utility [38] .
Finally, ultrasonography can assess splenic size, portal hypertension, and gallstones, which may be an economical, safe, first-line imaging approach.
The extent of splenectomy positively correlates with hematologic improvement. All studies agreed that TS adequately resolves anemia to normal or near-normal hemoglobin concentrations.
Hematologic values following PS remain stable for at least five years, and this should also be expected following TS. There is less erythropoiesis following splenectomy, though percent reticulocytes remain abnormally elevated due to residual hemolysis. It seems prudent to consider PS when modest improvements in hemoglobin and reticulocytes are required, and to consider TS in more severe instances.
Following splenectomy, residual hemolysis increases the risk of gallstone formation, and symptomatic gall stones or cholecystitis, especially with severe disease or delayed splenectomy [20] . Secondary TS is indicated when symptoms recur following PS, and is more likely to be required in severe disease. The genotypic and phenotypic severity of HS should be characterized to help predict patient outcome, as disease severity is a cumulative effect of spectrin and band 3
protein deficiency, or a relative imbalance in their abundance [39] . The level of methemoglobin bound to the erythrocyte membrane negatively affects the post-splenectomy hemoglobin concentration, another possible marker of outcome [39] .
An often cited concern for avoiding TS is that the risk of OPSS was perceived to be greater than that of PS. An older review of 5,902 TS cases produced an estimated post-operative sepsis rate of 4.4% and a mortality rate of 2.2% [40] . One meta-analysis observed post-operative sepsis rates of 5-12% for TS and 0-11% for PS [33] . However, these mortality rates included both adult and pediatric patients across several hemolytic disorders. The reason for the significantly reduced mortality in pediatric HS over the past two decades is mostly influenced by prophylactic antibiotics and vaccinations, and to delay elective splenectomy until age five [4, 41] . This delay is even reflected in the patient demographics (Table III) . Furthermore, no case of OPSS in a pediatric HS patient who has received prophylactic immunization and antibiotics were found.
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Whether the splenic remnant retains immune competency is uncertain. The resident population of IgM memory B cells in the spleen constitute a major defense against encapsulated bacteria. However, splenectomy severely reduces this B cell population [9] . Several documented cases of OPSS or serious bacterial infection in patients with splenosis or accessory spleen tissue have been documented [29, [42] [43] [44] , and some cases of fulminant pneumococcal infections occur more than 20 years after splenectomy [45] . There is no clear correlation that the volume of splenic regrowth or splenosis offers immune protection, and preliminary findings exacerbate this risk as immune protection declines with age independent of splenectomy [29, 46] . The immunogenic response to pneumococci and meningococci vaccination are also less than ideal following splenectomy performed for congenital hemolytic disorders [46] [47] [48] . This scanty data supports the extra concern noted in a recent review of vaccination guidelines for the care of hyposplenic individuals [49] . It remains unknown if splenectomized children experience more frequent bacterial infection in later adulthood.
There are limitations to this review. First, there is a limited length of follow-up. Second, these reports mostly represent experiences of single institutions, and are often based on a small patient sample. While these patients experience moderate to severe disease, this review focused on reports which endeavoured to use systematic collection procedures, such as institutional reviews, so as to limit some forms of selection bias. While the recovery of hemoglobin, resolution of hemolysis, prevention of cholelithiasis and the consequent hepatobiliary disease and future risk of vascular disease in HS patients are all important issues for both the clinician and the patient, the choice of TS vs PS in achieving an optimal outcome is not yet clear. 
Notes:
Terms within domains were combined using the OR Boolean operator, while combinations of domains were combined using the AND operator. & denotes MeSH major headings. All other search terms were text searches. * denotes a wildcard. 
Inclusion Criteria
Studies report hereditary spherocytosis patients undergoing any form of splenectomy with preand post-operative hematological parameters or markers of hemolysis, specifically: hemoglobin concentrations and peripheral reticulocyte proportion.
Studies report adverse events, surgical complications or mortality.
Studies followed a cohort, case-control or case series study design. When case series were reported, the chart review was conducted in an unbiased manner, such as an institutional review reporting on all cases of hereditary spherocytosis over a specified period of time.
Data were reported with the value of relative risk (RR), odds ratio (OR) or difference scores with 95% confidence intervals (CI); or the raw data needed to calculate these statistics.
Studies with English title and abstract (for searching), but whose full-text is available in English, Italian or French were included.
Exclusion Criteria
Single case reports or case series describing <4 patients. or studies that describe a single familial experience with HS.
Letters to the editor or commentaries that did not include full data of the splenectomized patients.
Splenectomies were performed secondary for any other indication than hereditary spherocytosis, including blunt trauma, thrombocytopenia purpura, sickle cell anemia, or cholelithiasis.
Data are reported in aggregate of hemolytic anemias, and the spherocytosis-specific data could not be obtained either from the article text or by correspondence with the author.
Studies which exclusively focus on only "mild" cases of spherocytosis, or adult cases, which are less likely to require surgical intervention.
Studies that include adult patients, but for which the individual data or subgroup data are not reported by age. Databases and registries searched 4 11 Search software used, name and version, including special features used (eg, explosion) 5 12
Use of hand searching (eg, reference lists of obtained articles) 4 13 List of citations located and those excluded, including justification Fig. 1 , pp. 5-6 14
Method of addressing articles published in languages other than English Table 2  15 Method of handling abstracts and unpublished studies Table 2  16 Description of any contact with authors 5 Reporting of methods should include 17 Description of relevance or appropriateness of studies assembled for assessing the hypothesis to be tested Justification for exclusion (eg, exclusion of non-English language citations) Table 2  31 Assessment of quality of included studies 
